Basilea Pharmaceutica International AG, Allschwil

Basilea Pharmaceutica International AG, Allschwil is recorded by Swissmedic as the authorisation holder for 2 human medicines, which places it 245 of 334 authorisation holders. Its portfolio is mostly in the Synthetika category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.

Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.

Key facts

SectorNot available
CityNot available
CantonNot available
Authorisation holderYes
Medicines2
FoundedNot available
EmployeesNot available
Parent groupNot available
ActivityNot available
WebsiteNot available

Medicines authorised in Switzerland

Basilea Pharmaceutica International AG, Allschwil is recorded by Swissmedic as the authorisation holder for 2 human medicines. The table shows 2 of them with product code and dispensing category.

Portfolio by product code

  • Synthetika2

Portfolio by dispensing category

  • A2

2 of 2 authorisations

NameAuthorisation numberDispensing categoryATCFirst authorised
Cresemba 100 mg66172AJ02AC052017-10-20
Cresemba 200mg66173AJ02AC052017-10-20

Frequently asked questions

How many medicines does Basilea Pharmaceutica International AG, Allschwil have authorised in Switzerland?

Basilea Pharmaceutica International AG, Allschwil is recorded by Swissmedic as the authorisation holder for 2 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.

Where is Basilea Pharmaceutica International AG, Allschwil based?

We have no confirmed Swiss address for Basilea Pharmaceutica International AG, Allschwil. We add it as soon as the commercial register or the company confirms it.

Is Basilea Pharmaceutica International AG, Allschwil a Swissmedic authorisation holder?

Yes. Basilea Pharmaceutica International AG, Allschwil appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.

Sources

Last updated:

Data from the Swissmedic list of authorised medicinal products as of 1 September 2026. We hold no research of our own on this company's location, sector or website.

About the operator

Swiss Pharma Partners

Public sources · Independent directory · Eight language versions

The Swiss Pharma Partners is an independent service and is neither affiliated with nor authorised by Swissmedic or the Federal Office of Public Health (FOPH).

Send enquiry
Ask for a Swiss partner

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swisspharmapartners.com